Value chain — stage 01

Discovery & preclinical

Target identification, generative chemistry, structure prediction, ADMET and the new approach methodologies replacing animal studies — what the models can and cannot do yet.

  • Target identification & validation
  • Generative & de-novo design
  • Structural biology
  • ADMET & translational safety
  • Lab automation